Read full article here. Lincoln Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2023. Financial Results (Q1 FY2024) – QoQ Comparison The company has reported total income of Rs. 143.3103 crores during the period ended June 30, 2023 as compared to Rs. 116.3588 crores during the period ended March 31,…
“In an exclusive interaction with CNBC Bazaar, Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd spoke about the company’s international business and growth outlook going ahead.
“In an exclusive interaction with CNBC Bazaar, Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd spoke about the company’s international business and growth outlook going ahead.
“In an exclusive interaction with CNBC Bazaar, Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd spoke about the company’s international business and growth outlook going ahead.
“In an exclusive interaction with CNBC Bazaar, Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd spoke about the company’s international business and growth outlook going ahead.
“In an exclusive interaction with CNBC Bazaar, Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd spoke about the company’s international business and growth outlook going ahead.
“In an exclusive interaction with CNBC Bazaar, Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd spoke about the company’s international business and growth outlook going ahead.
“In an exclusive interaction with Anil Singhvi, Zee Business, Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd spoke about the company’s international business and growth outlook going ahead.
“In an exclusive interaction with Shweta Papriwal, Editor, IIFL Securities, Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd spoke about the company’s international business and growth outlook going ahead.
Lincoln Pharmaceuticals on Thursday reported a 20.44 per cent rise in its consolidated net profit to Rs 15.26 crore for the quarter ended June 30, 2020.